<DOC>
	<DOCNO>NCT01325987</DOCNO>
	<brief_summary>Using randomize , placebo-controlled trial design subject vitamin D deficiency , investigator propose determine vitamin D treatment improve glycemic control vitamin D deficient subject T2DM . The investigator hypothesize oral vitamin D treatment improve glycemic control ÃŸ-cell function vitamin D deficient AA subject T2DM . The investigator hypothesize maintain serum 25 ( OH ) D concentration 20 ng/ml oral supplementation vitamin D additional glycemic control effect .</brief_summary>
	<brief_title>African American Children , Glycemic Control , Type 2 Diabetes</brief_title>
	<detailed_description>Current literature suggest 25-hydroxyvitamin D ( 25 ( OH ) D ) inversely relate risk type 2 diabetes mellitus ( T2DM ) . African Americans ( AA ) significantly less 25 ( OH ) D concentration , great chance poor glycemic control compare European Americans ( EA ) . The primary objective evaluate difference glycemic control child type 2 diabetes explain difference serum concentration 25 ( OH ) D. A secondary aim demonstrate subject vitamin D deficiency ( serum 25 ( OH ) D &lt; 20ng/ml ) T2DM receive 8 week vitamin D treatment ( 50,000 IU oral vitamin D2/once per week ) great improvement subject receive placebo glycemic control , measure HbA1c endogenous insulin secretion , assessed area concentration-time curve ( AUC ) mix meal-stimulated C peptide , 3 month study drug administration . Research design : Randomized , placebo-controlled , double blind study design child T2DM vitamin D deficiency . Glycemic control determine HbA1C level , fast glucose area curve ( AUC ) glucose mixed meal tolerance test ( MMTT ) . Measures beta cell function determine AUC c-peptide glucose MMTT . This study warrant AA adolescent T2DM positive intervention could life long impact lead future large clinical trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>Type 2 DM acanthosis African American 1218 year BMI &gt; 85 % Tanner Stage &gt; 4 Those take vitamin D Pregnancy Those chronic health condition diabetes Those deem medically unstable participate research</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Vitamin D deficiency</keyword>
	<keyword>Glycemic control</keyword>
</DOC>